Triangle Capital Corporation Announces Conference Call to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Triangle Capital Corporation Announces Conference Call to Discuss First Quarter 2015 Results

RALEIGH, N.C., April 14, 2015 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (NYSE: TCAP ) ("Triangle" or the "Company"), a leading provider of capital to lower middle market companies, today announced it has scheduled a conference call to discuss first quarter 2015 operating and financial results for Thursday, May 7, 2015, at 9:00 a.m. ET.

To listen to the call, please dial 877-312-5521 or 253-237-1143 approximately 10 minutes prior to the start of the call. A taped replay will be made available approximately two hours after the conclusion of the call and will remain available until May 11, 2015. To access the replay, please dial 855-859-2056 or 404-537-3406 and enter the passcode 24407148.

Triangle's quarterly results conference call will also be available via a live webcast on the investor relations section of its website at http://ir.tcap.com/events.cfm . Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website until June 5, 2015.

About Triangle Capital Corporation

Triangle Capital Corporation ( www.TCAP.com ) invests capital in established companies in the lower middle market to fund growth, changes of control and other corporate events. Triangle offers a wide variety of investment structures with a primary focus on mezzanine financing with equity components. Triangle's investment objective is to seek attractive returns by generating current income from debt investments and capital appreciation from equity related investments. Triangle's investment philosophy is to partner with business owners, management teams and financial sponsors to provide flexible financing solutions. Triangle typically invests $5.0 million - $35.0 million per transaction in companies with annual revenues between $20.0 million and $200.0 million and EBITDA between $5.0 million and $35.0 million.

Triangle has elected to be treated as a business development company under the Investment Company Act of 1940 ("1940 Act"). Triangle is required to comply with a series of regulatory requirements under the 1940 Act as well as applicable NYSE, federal and state laws and regulations. Triangle has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986. Failure to comply with any of the laws and regulations that apply to Triangle could have a material adverse effect on Triangle and its stockholders.

Forward Looking Statements

This press release may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any such statements, other than statements of historical fact, are likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under the Company's control, and that the Company may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from these estimates and projections of the future and some of these uncertainties are enumerated in Triangle's filings with the Securities and Exchange Commission. Certain factors that could cause actual results to differ materially from those contained in the forward-looking statements are included in our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, each as filed with the Securities and Exchange Commission. Copies are available on the SEC's website at www.sec.gov and stockholders may receive a hard copy of the completed audited financial statements free of charge upon request to the Company at 3700 Glenwood Avenue, Suite 530, Raleigh, NC 27612. Such statements speak only as of the time when made, and the Company undertakes no obligation to update any such statement now or in the future.

Sheri Blair Colquitt Vice President, Investor Relations 919-719-4784 Steven C. Lilly Chief Financial Officer 919-719-4789

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting New Development Partnership in Wasaga Beach Focuses on Growth

Updated Category News Views 262

New Development Partnership Announcement Sunray Group of Hotels is excited to announce a letter of intent for a new development project alongside the Town of Wasaga Beach. This venture, located at the intersection of First Street North and Beach Drive, is strategically positioned on four acres of valuable land across from Beach Area One. The proposed project consists of a...

Continue Reading
iGlobal Media USA Launches $500,000 Investment Round for Growth

Updated Category News Views 231

iGlobal Media USA Opens Investment Round for Expansion iGlobal Media USA, a leading name in digital broadcasting, is excited to announce a new opportunity for investors with a significant investment round aimed at raising $500,000. This funding will be pivotal for accelerating the national expansion of its advanced cloud-based radio platform, which promises to...

Continue Reading
STMicroelectronics Shares Update: Share Repurchase Program Details

Updated Category News Views 156

STMicroelectronics Shares Update on Repurchase Program STMicroelectronics N.V. (the "Company" or "STMicroelectronics"), a prominent name in the semiconductor industry, has actively engaged in a share repurchase program aimed at enhancing shareholder value. This program, initially revealed in a previous announcement, serves as a testament to the Company's commitment to...

Continue Reading
Chicago Mayor Brandon Johnson Set to Tackle Key Issues in D.C.

Updated Category News Views 103

Chicago Mayor Brandon Johnson to Speak at National Press Club Join us for an insightful luncheon featuring Chicago Mayor Brandon Johnson as he takes the stage at the National Press Club. This important event is set for the 28th of January, providing a platform for the Mayor to discuss pressing topics affecting residents. Event Overview The Headliners Luncheon will kick...

Continue Reading
BioCryst Pharmaceuticals Reveals HRU Improvements with ORLADEYO

Updated Category News Views 184

BioCryst Pharmaceuticals Introduces New HRU Findings BioCryst Pharmaceuticals, Inc. has recently shared compelling evidence regarding their product, ORLADEYO (berotralstat), that highlights its impact on reducing healthcare resource utilization for patients suffering from hereditary angioedema (HAE). This important finding underscores the therapy's role not only in...

Continue Reading